Using Generic and Disease-Specific Measures to Assess Quality of Life before and after 12 Months of Hearing Implant Use: A Prospective, Longitudinal, Multicenter, Observational Clinical Study
Authors:
- Luis LassalettaLLLuis Lassaletta
- Miryam CalvinoMCMiryam Calvino
- Isabel Sanchez-CuadradoISIsabel Sanchez-Cuadrado
- Piotr Henryk SkarzynskiPiotr Henryk Skarzynski
- Katarzyna B. CywkaKCKatarzyna B. Cywka
- Natalia CzajkaNatalia Czajka
- Justyna KutybaJKJustyna Kutyba
- Dayse Tavora-VieiraDTDayse Tavora-Vieira
- Paul van de HeyningPHPaul van de Heyning
- Griet MertensGMGriet Mertens
- Hinrich StaeckerHSHinrich Staecker
- Bryan HumphreyBHBryan Humphrey
Open Access
- 22 February 2022
- journal article
- research article
- Published by MDPI AG in International Journal of Environmental Research and Public Health
- Vol. 19 (5) , 2503
Abstract
The primary objectives of this study were to evaluate the effect of hearing implant (HI) use on quality of life (QoL) and to determine which QoL measure(s) quantify QoL with greater sensitivity in users of different types of HIs. Participants were adult cochlear implant (CI), active middle ear implant (VIBRANT SOUNDBRIDGE (VSB)), or active transcutaneous bone conduction implant (the BONEBRIDGE (BB)) recipients. Generic QoL and disease-specific QoL were assessed at three intervals: pre-activation, 6 months of device use, and 12 months of device use. 169 participants completed the study (110 CI, 18VSB, and 41BB). CI users’ QoL significantly increased from 0–6 m device use on both the generic- and the disease-specific measures. On some device-specific measures, their QoL also significantly increased between 6 and 12 m device use. VSB users’ QoL significantly increased between all tested intervals with the disease-specific measure but not the generic measure. BB users’ QoL significantly increased from 0–6 m device use on both the generic- and the disease-specific measures. In sum, HI users experienced significant postoperative increases in QoL within their first 12 m of device use, especially when disease-specific measures were used. Disease-specific QoL measures appeared to be more sensitive than their generic counterparts.Keywords
This publication has 35 references indexed in Scilit:
- Agreement between health utility instruments in cochlear implantationClinical Otolaryngology, 2016
- The Bonebridge Bone Conduction Hearing Implant: indication criteria, surgery and a systematic review of the literatureClinical Otolaryngology, 2016
- Does quality of life depend on speech recognition performance for adult cochlear implant users?The Laryngoscope, 2015
- Quality of life in cochlear implantees: Comparing utility values obtained through the Medical Outcome Study Short‐Form Survey‐6D and the Health Utility Index Mark 3The Laryngoscope, 2014
- Evaluation of cost-utility in middle ear implantation in the ‘Nordic School’: A multicenter study in Sweden and NorwayCochlear Implants International, 2014
- Validity and Reliability of the Assessment of Quality of Life (AQoL)-8D Multi-Attribute Utility InstrumentThe Patient - Patient-Centered Outcomes Research, 2013
- A short form of the Speech, Spatial and Qualities of Hearing scale suitable for clinical use: The SSQ12International Journal of Audiology, 2013
- The impact of cochlear implantation on quality of life: The role of audiologic performance and variablesOtolaryngology–Head and Neck Surgery, 2008
- The Health Utilities Index (HUI ® ): concepts, measurement properties and applicationsHealth and Quality of Life Outcomes, 2003
- Development and application of a health‐related quality‐of‐life instrument for adults with cochlear implants: The Nijmegen Cochlear Implant QuestionnaireOtolaryngology–Head and Neck Surgery, 2000